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Abstract
Background Physical activity (PA) is a recognized contributor to healthy aging. However, the majority of studies exploring its
associations with adverse outcomes in cohorts of older adults use single-time PA estimates, which do not consider its dynamic
nature. The aim of the present study is to explore the presence of different PA trajectories in the Toledo Study of Healthy Ag-
ing and their association with adverse outcomes. Our hypothesis is that prospectively maintaining or increasing PA is associ-
ated with a reduced risk of adverse outcomes.
Methods We used data from 1679 participants enrolled in the Toledo Study of Healthy Aging. Trajectories based on the
Physical Activity Scale for the Elderly were identified using group-based trajectory modelling. Cox and logistic regression were
used to investigate associations between PA trajectories and mortality and hospitalization, and incident and worsening disabil-
ity, respectively. Mortality was ascertained by linkage to the Spanish National Death Index; disability was evaluated through
the Katz Index; and hospitalization was defined as the first admission to Toledo Hospital. Models were adjusted by age, sex,
smoking, Charlson Index, education, cognitive impairment, polypharmacy, and Katz Index at Wave 2.
Results We found four PA-decreasing and one PA-increasing trajectories: high PA-consistent (n = 566), moderate PA-mildly
decreasing (n = 392), low PA-increasing (n = 237), moderate PA-consistent (n = 191), and low PA-decreasing (n = 293). Belong-
ing to the high PA-consistent trajectory group was associated with reduced risks of mortality as compared with the low PA-
decreasing group [hazard ratio (HR) 1.68; 95% confidence interval (CI) = 1.21–2.31] and hospitalization compared with the
low PA-increasing and low PA-decreasing trajectory groups (HR 1.24; 95% CI = 1.004–1.54 and HR 1.25; 95% CI = 1.01–1.55,
respectively) and with lower rates of incident [odds ratio (OR) 3.14; 95% CI = 1.59–6.19] and worsening disability (OR 2.16;
95% CI = 1.35–3.45) in relation to the low PA-decreasing trajectory group and at follow-up. Increasing PA during late life
(low PA-increasing group) was associated with lower incident disability rates (OR 0.38; 95% CI = 0.19–0.82) compared with de-
creasing PA (low PA-decreasing group), despite similar baseline PA.
Conclusions Our results suggest that sustaining higher PA levels during aging might lead to healthy aging, characterized by a
reduction in adverse outcomes. Our study supports the need for enhancing PA participation among older populations, with the
goal of reducing personal and economic burden in a worldwide aging population.
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Introduction
Lifelong physical activity (PA) promotes a wide range of
health benefits and has long been recognized as an important
protective factor for chronic diseases.1–6 These beneficial ef-
fects consistently translate into lower mortality rates in both
men and women.7–12
The salutary effects of PA might extend to late life, as it is
known to delay the onset of disability13,14 and to increase
lifespan.7,8,15,16 Furthermore, PA might be negatively associ-
ated with other adverse outcomes such as hospitalization,
thereby reducing health care expenditure.17,18 Remarkably,
at advanced ages, PA levels might surpass other cardiovascu-
lar or sociodemographic risk factors that are classically associ-
ated with adverse outcomes in younger cohorts.19,20
The World Health Organization defines ‘healthy aging’ as
the process of developing and maintaining the functional abil-
ity that enables well-being in older age.21 Accordingly, PA is
suggested to be an important contributor to healthy aging
through the maintenance and enhancement of intrinsic ca-
pacity—mental and especially physical capacities.22 A com-
mon methodological limitation in exploring the association
between PA and adverse outcomes in older populations is
the use of a single time-point assessment of PA (primarily
the baseline PA levels) as the exposure variable,23–29 which
does not account for the dynamic nature of PA behaviours.30
It is plausible that prospective trajectories (patterns) of PA
levels along time in late life may influence adverse outcomes
distinctly as compared with cross-sectional estimates,31,32 a
hypothesis that remains untested to our knowledge.
Some studies have recently addressed this shortcoming
and used prospective PA level evolution as the exposure var-
iable. Most of these studies employed categorical analyses
with clinical or empirical cut-points for identifying groups
with different PA progression patterns.9,33–35
Data-driven approaches such as group-based trajectory
modelling (GBTM) have emerged as an informative and inter-
esting analytical method that allows grouping of subjects pre-
senting with similar baseline values and longitudinal patterns
of change, in terms of their direction and magnitude, along
follow-up for a given variable within a population.36,37 Using
this methodology, some studies have shown the existence
of different PA level trajectories in older adult cohorts,30,38
and one study explored their associations with mortality in
a sample of older men.39
The main aim of this study is to investigate the existence of
different PA trajectories within the Toledo Study of Healthy
Aging (TSHA) sample, a Spanish longitudinal population-based
study, and to evaluate their associations with adverse out-
comes (mortality, disability onset and worsening, and hospi-
talization). Our hypothesis is that chronically active subjects
and those maintaining PA over time will have a lower likeli-
hood of experiencing adverse outcomes compared with con-
sistently inactive subjects or those reducing PA levels during
follow-up and that increasing PA even at older ages promotes
healthy aging, as characterized by reduced mortality, disabil-
ity onset/worsening, and hospitalization rates.
Methods
Study design and participants
Data were taken from the TSHA study, the details of which
have been reported elsewhere.40 Briefly, this is a
population-based prospective cohort study examining the de-
terminants and consequences of frailty in institutionalized
and community-dwelling individuals older than 65 years living
in the province of Toledo (Spain). For the present analysis, we
used data from those subjects with non-missing PA scores
from the first (2006–2009) and second (2011–2013) TSHA
waves and available mortality and hospitalization information
at the censoring time and functional ability from the third
wave (2015–2017).
The Clinical Research Ethics Committee of Toledo Hospital,
Spain, approved the study protocol, and participants signed
an informed consent prior to their inclusion in the study.
Measures
Physical Activity Scale for the Elderly
Physical activity levels were estimated using the Physical Ac-
tivity Scale for the Elderly (PASE). This questionnaire was de-
signed to assess PA in epidemiologic studies of older people
over a 1 week period. It ascertains the duration, intensity,
and frequency of several activities and consists of 10 items
that focus on three domains: leisure (five components),
household (four), and work (one) activities. Participation in
leisurely activities is recorded by frequency (e.g. never, sel-
dom, sometimes, and often) and duration (e.g. less than an
hour, 2–4 h, or >4 h); paid or unpaid work is recorded by to-
tal hours of work per week; and household activities and care
for others are recorded with yes or no answers. Total PASE
score is calculated by multiplying activity participation (yes/
no) or the amount of time spent on each activity (hours/
week) by empirically derived item weights, which are
summed.41 In the present study, PASE was administered by
interview, because this modality has proven superior reliabil-
ity than self-administration.42 We used PASE scores from
Wave 1 and Wave 2 to construct the trajectories.
Mortality
Vital status was ascertained through the information pro-
vided by the Spanish National Death Index (Ministry of Health
and Social Services). Participants were followed up to death
or June 2018, whichever came first. The average follow-up
for mortality was 5.92 years (range 0.01–7.5 years).
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Hospitalization
Hospitalization was ascertained by review of the Toledo Hos-
pital Complex records and was defined as the occurrence of a
first admission to the hospital during follow-up, up to Decem-
ber 2016. Median follow-up for hospitalization was 4.08 years
(range 0.01–5.24 years).
Disability and worsening disability
The Katz Index was used to assess the functional ability in ba-
sic activities of daily living (BADLs).43 Incident disability was
defined as the transition from a score of 6 to 5 or less in
the Katz Index at follow-up. Worsening disability at follow-
up was defined as the advent of a new difficulty in the Katz
Index at follow-up in those participants with a prevalent dis-
ability at baseline. Median follow-up for disability
onset/worsening was 2.99 years (range 2–5.4 years).
Covariates
We selected covariates based on the literature and the bio-
logical plausibility for confounding the main associations of
interest. Age, sex, education (non-educated, non-finished pri-
mary education, and finished primary education/superior),
and smoking status (yes/past/never) were registered during
study visits. Presence of co-morbidities was ascertained by
self-report and by checking the medical history to compute
the Charlson Index score.44 Body mass index was computed
using the standard formula (body mass × height2). Cognitive
status was assessed by using the Mini-Mental State Examina-
tion (MMSE).45 The number of prescription and non-
prescription drugs within the Anatomical Therapeutic Chemi-
cal Classification System taken by the participant was calcu-
lated. Polypharmacy was defined as the intake of ≥5 drugs
per day.46 All covariates were measured at Wave 2
assessment.
Statistical analysis
Descriptive analysis
All analyses were performed using the R statistical environ-
ment for Windows. Mean (standard deviation) and frequency
(percentage) are provided for continuous and categorical var-
iables, respectively. Descriptive variables were compared be-
tween included and excluded subjects and between
trajectories with an independent Student’s t-test or analysis
of variance for continuous variables and the χ2 test for cate-
gorical variables.
Trajectory modelling
We used a GBTM approach to identify PA trajectories within
our population. This type of finite mixture model provides an
empirical means of identifying clusters of individuals defined
by their developmental courses for a variable over time (tra-
jectories) within a population. Briefly, this method assumes
that the general population is composed of literally distinct
subpopulations that are not identifiable based on measured
characteristics ex ante. In GBTM, each group is conceptually
thought of a collection of individuals who follow approxi-
mately the same developmental trajectory, where population
variability is captured by differences across groups in the
shape and direction of their trajectories.37 First, the best
model among those with different number of classes (trajec-
tories) was identified by using Bayesian information criterion
(BIC). BIC is an index used in Bayesian statistics to choose be-
tween two or more alternative models, given the data. In our
study, two times the change in the BIC between models
greater than 10 was used as indicative of better fit in order
to compare more complex—with a greater number of trajec-
tories—vs. more parsimonious—with a lower number of tra-
jectories—models.47 Each subject was assigned to a
trajectory depending upon his individual values (baseline
PASE score and progression patterns). Second, average poste-
rior probabilities of membership were computed for each
group to estimate the reliability of the classification. Individ-
ual posterior probability of membership for a subject repre-
sents his probability of belonging to the group he is
assigned to by previous grouping based on his individual fea-
tures. Trajectory average posterior probability of membership
represents its internal consistency, with higher values indicat-
ing better classification quality.37 We finally checked the
number of subjects within each trajectory to ensure ade-
quate sample size for assessing the subsequent risk of ad-
verse outcomes.
Associations between physical activity trajectories and ad-
verse events
Cox proportional hazards regression was used to investigate
the associations between the GBTM-derived PA trajectories
and the adverse outcomes for which we had the date of oc-
currence (mortality and hospitalization). Logistic regression
analysis was used for disability onset and disability worsening
(that were registered during study visits). Multivariate trajec-
tory models were adjusted for age and sex (Model 1), plus
Charlson Index (Model 2), and additionally for baseline Katz
Index, level of education, polypharmacy, cognitive status
(MMSE), and smoking status (Model 3).
Results
Baseline characteristics of the subjects within each trajectory
are presented in Table 1; 1679 subjects (67.48% of TSHA
whole sample; mean age = 74.26 ± 5.32; 41% men) had data
available for the purpose of this analysis. Not-included sub-
jects were significantly older and had lower scores for the
MMSE, Charlson Index, and Katz Index (Supporting Informa-
tion, Table S1).
Group-based trajectory modelling yielded five PA trajecto-
ries as the best model: (i) high PA-consistent (n = 566; 33.7%),
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(ii) moderate PA-mildly decreasing (n = 392; 23.3%), (iii) low
PA-increasing (n = 237; 14.1%), (iv) moderate PA-consistent
(n = 191; 11.7%), and (v) low PA-decreasing (n = 293,
17.5%) (Figure 1). The mean posterior probability of member-
ship, an index of quality classification used in GBTM like ours,
was 0.79 ± 0.65, indicating an acceptable classification of the
subjects within each PA trajectory.
In the Cox regression model, subjects in the low PA-
decreasing trajectory group had a higher mortality risk than
peers in the reference group (high PA-consistent) across all
models [hazard ratio (HR) 1.68; 95% confidence interval
(CI) = 1.21–2.31 in the fully adjusted model (Model 3);
Table 2, Figure 2].
Subjects in the low PA-increasing [HR 1.24; 95% CI = 1.004–
1.54 (Model 3)] and low PA-decreasing [HR 1.25; 95%
CI = 1.01–1.55 (Model 3)] trajectory groups showed a signifi-
cant increase in the likelihood of hospitalization when com-
pared with subjects in the high PA-consistent group, across
all models (Table 2, Figure 2).
In the ‘raw’ model, logistic regression analysis showed a
greater risk of progressing into incident disability across all
the trajectories as compared with the reference high PA-
consistent group. These associations weakened as covariates
were included in the models but remained significant for the
low PA-decreasing trajectory group [odds ratio (OR) 3.14;
95% CI = 1.59–6.19 (Model 3)].
The low PA-decreasing trajectory group showed significant
increased risk of worsening disability when compared with
subjects classified into the high PA-consistent group (OR
2.16; 95% CI = 1.35–3.45 (Model 3); Table 2, Figure 2).
We additionally sought to compare groups with similar
baseline PA (similar starting risk) but divergent PA trends
along time (low PA-increasing vs. low PA-decreasing trajec-
tory groups). Subjects in the low PA-decreasing trajectory
group were more likely to be women (56% vs. 39%;
P = 0.001), to be older (78.9 vs. 74.4 years; P < 0.0001),
and to have difficulties in one or more BADLs at baseline
(39.7% vs. 25.6%; P = 0.0032).
Taking the low PA-decreasing as the reference, subjects
in the low PA-increasing trajectory showed a significantly
lower risk for disability onset (OR 0.39; 95% CI = 0.19–
0.82; Figure 3) in the fully adjusted model. We failed to find
differences between these two trajectories in terms of mor-
tality, hospitalization, or worsening disability risks.
Sensitivity analyses excluding subjects with posterior prob-
abilities <0.5 (n = 65; 3.87% of the sample) for the group they
were classified into did not meaningfully change the
associations.30
Discussion
The present study aimed at identifying PA trajectories in the
TSHA and exploring their association with adverse outcomes.Ta
b
le
1
B
as
el
in
e
ch
ar
ac
te
ri
st
ic
s
o
f
th
e
sa
m
p
le
H
PA
C
n
=
56
6;
33
.7
%
M
PA
M
D
n
=
39
2;
23
.3
%
LP
A
I
n
=
19
1;
11
.7
%
M
PA
C
n
=
29
3;
17
.5
%
LP
A
D
n
=
23
7;
14
.1
%
W
ho
le
sa
m
pl
e
n
=
16
79
Be
tw
ee
n-
gr
ou
ps
di
ff
er
en
ce
s
(P
va
lu
e)
A
ge
,m
ea
n
(S
D
)
72
.3
7
(4
.4
1)
73
.7
6
(4
.8
3)
74
.9
4
(5
.0
6)
72
.4
2
(4
.4
1)
78
.9
(5
.5
6)
74
.9
4
(5
.0
6)
<
0.
00
1
M
en
,n
(%
)
28
7
(5
0.
71
)
15
6
(3
9.
79
)
10
7
(5
6.
02
)
57
(1
9.
45
)
94
(3
9.
66
)
70
1
(4
1.
74
)
<
0.
00
1
BM
I,
m
ea
n
(S
D
),
kg
m
2
28
.9
(4
.1
)
29
.3
(4
.5
)
30
.1
(5
.6
)
29
.5
(5
.1
)
29
.9
(5
.2
)
29
.4
(4
.7
)
<
0.
05
C
ur
re
nt
sm
ok
er
,n
(%
)
18
1
(3
1.
98
)
10
9
(2
7.
81
)
77
(4
0.
31
)
45
(1
5.
36
)
60
(2
5.
32
)
47
2
(2
8.
11
)
<
0.
00
1
BA
D
L
di
sa
bi
lit
y,
n
(%
)
37
(6
.5
4)
45
(1
1.
48
)
49
(2
6.
06
)
42
(1
4.
33
)
94
(3
9.
66
)
26
7
(1
5.
9)
<
0.
00
1
M
M
SE
sc
or
e,
m
ea
n
(S
D
)
25
.4
7
(3
.8
)
24
.0
2
(4
.3
7)
22
.5
6
(5
.9
1)
23
.5
(3
.9
6)
20
.3
4
(7
.1
4)
23
.8
(5
.0
7)
<
0.
00
1
C
ha
rl
so
n
In
de
x,
m
ea
n
(S
D
)
0.
82
(1
.3
3)
1.
02
(1
.4
5)
1.
37
(1
.7
1)
1.
02
(1
.5
6)
1.
45
(1
.9
)
1.
05
(1
.5
5)
<
0.
00
1
D
ep
re
ss
io
n
(G
D
S
≥
5)
,n
(%
)
48
(9
.7
6)
45
(1
2.
71
)
47
(2
7.
01
)
52
(1
9.
11
)
59
(2
9.
21
)
25
1
(1
6.
8)
<
0.
00
1
PA
SE
sc
or
e,
m
ea
n
(S
D
)
11
5.
61
(4
9.
15
)
80
.6
5
(1
1.
32
)
21
.5
3
(1
1.
88
)
53
.2
7
(3
.8
2)
28
.7
4
(2
0.
81
)
73
.6
(4
6.
85
)
<
0.
00
1
Δ
in
PA
SE
,m
ea
n
(S
D
)
3
.2
6
(1
8.
24
)
5
.6
4
(7
.2
2)
5.
92
(6
.2
7)
0.
87
(5
.9
7)
4
.6
9
(3
.7
4)
2
.2
5
(1
2.
24
)
<
0.
00
1
D
at
a
ar
e
pr
es
en
te
d
as
m
ea
n
(S
D
)o
r
n
(%
).
Si
gn
ifi
ca
nt
di
ff
er
en
ce
s
be
tw
ee
n
m
en
an
d
w
om
en
gr
ou
ps
w
er
e
an
al
ys
ed
by
St
ud
en
t’
s
t-
te
st
or
χ2
te
st
.B
A
D
L,
ba
si
c
ac
ti
vi
ty
of
da
ily
liv
in
g;
BM
I,
bo
dy
m
as
s
in
de
x;
G
D
S,
G
er
ia
tr
ic
D
ep
re
ss
io
n
Sc
al
e;
H
PA
C
,h
ig
h
PA
-c
on
si
st
en
t;
LP
A
D
,l
ow
PA
-d
ec
re
as
in
g;
LP
A
I,
lo
w
PA
-in
cr
ea
si
ng
;M
M
SE
,M
in
i-M
en
ta
lS
ta
te
Ex
am
in
at
io
n;
M
PA
C
,m
od
er
at
e
PA
-c
on
si
st
en
t;
M
PA
M
D
,m
od
er
at
e
PA
-m
ild
ly
de
cr
ea
si
ng
;P
A
,p
hy
si
ca
la
ct
iv
it
y;
PA
SE
,P
hy
si
ca
lA
ct
iv
it
y
Sc
al
e
fo
r
th
e
El
de
rly
;S
D
,s
ta
nd
ar
d
de
vi
at
io
n;
Δ
,c
ha
ng
e.
4 J.L. Sanchez-Sanchez et al.
Journal of Cachexia, Sarcopenia and Muscle 2020
DOI: 10.1002/jcsm.12566
Overall, our study shows that in this large representative co-
hort of older adults, prospectively maintaining higher base-
line PA levels at older ages is associated with a lower risk of
relevant adverse outcomes (mortality, disability onset and
worsening, and hospitalization), independently of important
confounding factors. Subjects showing higher PA levels at
Table 2 Multivariate associations between physical activity trajectories and adverse outcomes
HPAC
n = 566; 33.7%
MPAMD
n = 392; 23.3%
LPAI
n = 237; 14.1%
MPAC
n = 191; 11.7%
LPAD
n = 293; 17.5%
Mortality (HR; 95% CI)
Raw model Reference 1.41 (1.04–1.91)* 2.26 (1.62–3.14)*** 1.27 (0.9–1.79) 5.15 (3.92–6.77)***
Model 1 1.19 (0.88–1.63) 1.56 (1.12–2.19)** 1.15 (0.8–1.64) 2.53 (1.86–3.44)***
Model 2 1.13 (0.83–1.54) 1.4 (0.99–1.97) 1.08 (0.76–1.55) 2.21 (1.62–3.03)***
Model 3 1.01 (0.74–1.39) 1.26 (0.89–1.78) 0.97 (0.68–1.4) 1.68 (1.21–2.31)**
Hospitalization (HR; 95% CI)
Raw model Reference 1.1 (0.92–1.32) 1.68 (1.37–2.05)*** 1.19 (0.98–1.45) 2.22 (1.85–2.66)***
Model 1 1.04 (0.86–1.25) 1.43 (1.16–1.77)*** 1.2 (0.98–1.47) 1.68 (1.37–2.07)***
Model 2 1.01 (0.84–1.21) 1.33 (1.08–1.64)** 1.15 (0.93–1.4) 1.48 (1.2–1.83)***
Model 3 0.97 (0.8–1.17) 1.24 (1.004–1.54)* 1.05 (0.86–1.3) 1.25 (1.01–1.55)*
Disability (OR; 95% CI)
Raw model Reference 1.84 (1.27–2.66)** 1.93 (1.21–3.09)** 1.66 (1.1–2.51)* 4.93 (2.62–9.28)***
Model 1 1.5 (1.02–2.2)* 1.5 (0.92–2.46) 1.23 (0.79–1.91) 3.39 (1.74–6.59)***
Model 2 1.51 (1.03–2.21)* 1.41 (0.86–2.32) 1.24 (0.8–1.94) 3.31 (1.7–6.48)***
Model 3 1.44 (0.97–2.13) 1.22 (0.73–2.04) 1.13 (0.72–1.78) 3.14 (1.59–6.19)***
Disability worsening (OR; 95% CI)
Raw model Reference 1.71 (1.22–2.38)** 1.99 (1.31–3.02)** 1.75 (1.21–2.52)** 3.33 (2.23–4.98)***
Model 1 1.46 (1.04–2.06)* 1.61 (1.05–2.49)* 1.48 (1.01–2.18)* 2.05 (1.3–3.18)**
Model 2 1.45 (1.03–2.04)* 1.52 (0.99–2.36) 1.47 (1.002–2.17)* 1.86 (1.19–2.91)**
Model 3 1.41 (0.99–2.01) 1.28 (0.81–2.02) 1.32 (0.89–1.97) 2.16 (1.35–3.45)**
Model 1 (age and gender); Model 2 (age, gender, and Charlson Index); Model 3 (age, gender, Charlson Index, Mini-Mental State Exami-
nation, educational level, smoking status, Katz Index, and polypharmacy). CI, confidence interval; HPAC, high PA-consistent; HR, hazard
ratio; LPAD, low PA-decreasing; LPAI, low PA-increasing; MPAC, moderate PA-consistent; MPAMD, moderate PA-mildly decreasing; OR,
odds ratio; PA, physical activity.
*P < 0.05.
**P < 0.01.
***P < 0.001.
Figure 1 Physical activity (PA) trajectories by age. N = 1679; PA groups based on self-reported PA via PASE scores. HPAC, high PA-consistent; LPAD, low
PA-decreasing; LPAI, low PA-increasing; MPAC, moderate PA-consistent; MPAMD, moderate PA-mildly decreasing; PASE, Physical Activity Scale for the
Elderly.
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baseline and sustaining them along time (high PA-consistent
trajectory) had lower odds of all adverse outcomes compared
with those presenting with low baseline PA levels and an im-
portant decline along time (low PA-decreasing trajectory) and
lower risk for hospitalization than those with a low initial
PASE score even when PA increased over time (low PA-
increasing trajectory). These findings support the need to
promote effective intervention strategies aiming to maintain
Figure 3 Forest plots of the differences in the risk of adverse outcomes between the low physical activity-increasing and low physical activity-decreas-
ing trajectory groups. CI, confidence interval; HR, hazard ratio; OR, odds ratio. *P < 0.05; **P < 0.01; ***P < 0.001. LPAD, low PA-decreasing; LPAI, low
PA-increasing.
Figure 2 Forest plots of the risk of the different adverse outcomes in the different physical activity trajectory groups. CI, confidence interval; HR, haz-
ard ratio; OR, odds ratio. *P < 0.05; **P < 0.01; ***P < 0.001. HPAC, high PA-consistent; LPAD, low PA-decreasing; LPAI, low PA-increasing; MPAC,
moderate PA-consistent; MPAMD, moderate PA-mildly decreasing.
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or increase PA among older adults, as a key factor for healthy
aging.
We identified five longitudinal trajectories within our pop-
ulation. Of these, four showed a prospective reduction in PA
at old age, which agrees with previous observations of a ma-
jority of older adults reducing PA along time.48 Of special
note is the presence of one PA-increasing trajectory (low
PA-increasing), suggesting the existence of qualitatively dis-
tinct trajectories in our population of interest, as previously
described in other works,49–54 and extending the findings of
classical studies describing heterogeneous patterns of free-
living PA at older ages.55
Regarding the GBTM algorithm classification quality, the
identified trajectory groups showed mean posterior probabil-
ities of membership that were close to 0.8. As values of 0.7–
0.8 are deemed indicative of an aggrupation that sufficiently
discriminates between individuals with dissimilar patterns of
change in a behaviour over time,56 we conclude that our clas-
sification is reliable.
In relation to the association of prospective PA changes
and mortality, our results showing an increased risk for the
low PA-decreasing in relation to high PA-consistent trajectory
groups are consistent with the general notion that increased
levels of PA lead to greater longevity in both men and
women. These findings were also observed when using
cross-sectional PA estimates,9,20,23,25,27–29 prospective cate-
gorical changes in PA,9,33,57 and more recently, finite mixture
modelling approaches for PA trajectories identification as the
exposure variable,39 irrespective of the PA-estimation tool
(self-reported vs. objective measures).58 While it is known
that even a low level of participation in PA reduces mortality
rates in comparison with inactive behaviour,8,27,28 the bene-
fits increase in a dose–response manner at older ages in both
men and women, with a saturation effect in the upper limit of
both intensity and volume of PA.23 Interestingly, the magni-
tude of PA effect on mortality might be contingent upon
the intensity of the displaced activity, which underscores
the importance of this parameter as a determinant of PA ef-
fects on health.59
Importantly, the mortality-sparing benefits of late-life PA
might only be slightly affected by pre-cohort PA behaviour,60
meaning that at advanced age, even subjects that have never
engaged in PA might gain similar benefits to those that used
to be active. Additionally, PA seems to attenuate the excess
risk of mortality associated with other classical predictors
such as frailty,61 cognitive impairment,62 and poor mental,
social, and physical health among elders.63
Because PA is a powerful countermeasureagainst the de-
velopment and progression of chronic conditions, it is as-
sumed toconstitute a means to reduce healthcare system
utilization 64. In thiscontext, our results point to an important
reduction in the likelihood ofhospitalization among those re-
maining active along time (High PA-Consistenttrajectory) ver-
sus those showing low PA baseline levels (Low PA-Increasing
andLow PA-Decreasing trajectories). The little research that
is available hasdemonstrated that PA is related to fewer
and shorter hospital admissions 65,66.
With regard to the association between PA and disability
onset, our results support previous work reporting an inverse
association,14,67 with greater PA levels (measured heteroge-
neously) associated with lower likelihood of functional dis-
ability captured as mobility,67,68 clusters of BADL,69,70
instrumental activities of daily living,69,70 or both.69–71 The in-
verse PA–disability association seems to be graded, because
slight increases in terms of volume71 and intensity72 are asso-
ciated with significantly better functionality.
Yu et al. sought to explore associations between PA trajec-
tories and functionality in a Taiwanese older adult cohort of
3186 subjects (mean age 63.89 ± 8.17 years; 50% women)
using a growth mixture model along 11 years follow-up.73
Notwithstanding the differences in methodology between
their study and ours, the results were similar. Importantly,
and analogous to our findings, their PA-increasing trajectory
group benefitted from protection against disability to a simi-
lar extent as those who remained highly active along follow-
up, despite their low baseline PA levels.73
Regarding the associations between PA levels and disability
worsening, the limited evidence points to a negative associa-
tion between higher activity levels (measured in diverse
ways) and the odds of showing lower functionality at
follow-up. In this line, Tak et al. performed a meta-analysis
of four studies that reported associations between PA and
BADL disability progression.14 These findings are also compat-
ible with our data. Given the paucity of studies, further re-
search is needed to study the complex relationships
between PA and other determinants of disability.
The low PA-increasing trajectory group showed an in-
creased risk of hospitalization, but not disability, when com-
pared with the high PA-consistent group. We hypothesize
that the strong association between increasing activity and
functionality during late life might arise as the result of actual
improvements in the physical domain of intrinsic capacity
resulting from PA. Tellingly, associations between PA and
functionality tend to be stronger in the case of motor activi-
ties of daily living,54,66 whereas the associations with perfor-
mance on more cognitive demanding tasks might be more
modest.69,74 On the other hand, the absence of significant re-
ductions in hospitalization in the low PA-increasing trajectory
group observed here might suggest a limited potential of
late-life increases in PA to avoid outcomes that lead to hospi-
talization in elderly populations—mainly cardiovascular
events, pulmonary disease exacerbations, and fractures
resulting from lifelong development of prevalent conditions
in the presence of low PA levels. Accordingly, members of
more active trajectories are more likely to have been active
during mild life, and thus, their odds of developing these con-
ditions and subsequently being admitted to the hospital
might be lower.
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Our study has several strengths including the large sample
size, excellent ascertainment of adverse outcomes, and the
inclusion of relevant variables that could confound the asso-
ciations. The TSHA is a representative population of
community-dwelling and institutionalized men and women
with a wide range of ages and both. Furthermore, we used
the novel GBTM, a powerful statistical tool to group subjects
into qualitatively distinct developmental progressions that
differ not only at baseline but also in the direction and mag-
nitude of the change and that are not readily identifiable
using ad hoc, ex ante classification rules. By doing so, we
accounted for the factual dynamic nature of PA, overcoming
bias of previous research. Although GBTMmight remain unfa-
miliar for most of clinical focused researchers, it presents
some compelling features that might be quite useful to study
longitudinal data. The characterization of groups of subjects
following different evolutions for a variable has commonly re-
lied on subjective categorization based on clinical or empirical
thresholds (cut-points derived in other cohorts, tertiles, etc.).
Although reasonable, these assignment rules present with
some pitfalls. First, the existence of different groups is as-
sumed a priori, and this point cannot be tested objectively.
Second, they do not allow for assessing the precision of indi-
vidual classifications to the various groups, and hence, uncer-
tainty about individual group membership might emerge. In
our case, an important strength of GBTM is that it allows
for a data-based in-depth study of the features of potential
healthy aging phenotypes (PA-maintainers/increasers), which
in turn could help clinicians to identify strategies for main-
taining PA engagement among the elderly. To estimate PA
levels, we used a well-validated tool specific for older adults,
whose advantages include its brevity, easy scoring process,
the inclusion of activities other than exercise, and the inclu-
sion of activities common to older ensuring a comprehensive
assessment of overall PA. While objective PA measures are
more reliable and overcome PA questionnaires’ limitations,
they might be impractical in large cohorts, as in ours. This
work is one of the first to our knowledge trying to explore
the presence of different PA trajectories within a cohort of
older adults and their associations with important adverse
outcomes in an older adult cohort.
Our study, nevertheless, has important limitations. First,
self-reported PA tools are poorly correlated with objectively
measured PA, and their use is subject to the inclusion of recall
errors and social desirability leading to bias, especially among
older adults. Additionally, over-reporting of PA levels, if pres-
ent, would lead to an underestimation of the actual effect of
PA on adverse outcomes.7,32 Second, PASE cannot be trans-
lated into actual PA levels or the metabolic equivalent of task
or time performing exercise. Thus, it fails at directly account-
ing for important modulators of the effect of PA on health,
mainly intensity and volume. This makes our results challeng-
ing to interpret in relationship with other studies or PA rec-
ommendations. Third, hospitalization was only ascertained
by checking Toledo Hospital Complex records. Although this
centre is the reference hospital for the Toledo’s province,
where the whole sample dwelled at baseline, it is possible
that some subjects have travelled or moved during follow-
up and some events could have gone unreported.
Although GBTM is increasingly been used for identifying
trajectories for both exposures and outcomes in observa-
tional and experimental research, it is inherently limited in
capturing individual variability and may lead to over-
grouping.36 Furthermore, we could only construct linear tra-
jectories because we could only evaluate two time-points
prior to follow-up.
Reverse causality cannot be excluded in our study, due to
its observational nature. PA participation might be condi-
tioned by health status and vice versa. Nevertheless, the as-
sociations remained significant after adjustment for
important risk factors, co-morbidities, and functional status.
We acknowledge the potential absence of unrecognized or
uncontrolled covariates that could affect our observations. Of
note is the absence of a measure of sedentary behaviour as a
competing exposure. Sedentary behaviour has recently been
postulated as a key health factor, independent of PA pat-
terns, and is associated with mortality,75,76 disability,69,77
and increased health care expenditure.78 Furthermore, as
we did not have information about PA before the study entry
time, we are not able to assess whether the benefit from PA
observed in this study could respond to a lifelong acquired
benefit rather than to a recently gained PA beneficial effect.
Direct comparison of our study with others is not possible
due to the unique distribution of trajectories that GBTM
yields within individual populations. Finally, our sample is re-
stricted to a specific area of Spain with unique features.
Although this fact may limit the generalizability of our results,
it offers the advantage of reduced potential confounding
by race, education, social economic class, and access to
health care.
Our study contributes to expand the notion of PA as a
powerful modifiable factor that promotes healthy aging by
means of preventing important adverse outcomes including
mortality, disability, and hospitalization. It does so from a
new perspective, by using a novel approach that allows to
empirically identify different PA-related aging phenotypes,
that as our results suggest, are associated with relevant out-
comes for older people. The prevention of BADL disability is
especially relevant, because it is associated with receiving
home care services and an increased risk of long-term nursing
home admission and health care costs.14 In the context of a
global aging population, our findings have important clinical
and economic implications. Given that the association be-
tween PA and healthy aging seems to be valid and physiolog-
ically plausible, especially if the PA is in the form of structured
exercise, the goal should be to enhance exercise participation
among older people living in the community. Unfortunately,
PA levels fall dramatically in the last years of life.20 If, as the
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evidence indicates, any activity above sedentarism in terms of
volume8,27–29,35 and intensity,23,32,59 and longitudinally main-
taining PA levels, are associated with better health outcomes
in older adults,27,29,79 clinicians, relatives, and caregivers
should encourage them to be as active as possible, both dur-
ing planned exercise sessions and in everyday life activities.
Policymakers, for their part, should increase social awareness
and promote accessible, popular, and everyday activities such
as walking and active commuting among older populations.
Hopefully, efforts are being made to increase late-life PA
participation.80
In summary, we confirmed our hypotheses in our older
adult cohort that consistent high PA levels provide protection
against important adverse outcomes when compared with
low PA baseline levels and decreasing PA. Importantly, in-
creasing PA levels during late life might entail a lower risk
of disability in comparison with prospectively reducing
activity.
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